Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JIMD Reports is Scopus-indexed (Q2, CiteScore 3.3), WoS ESCI, DOAJ. Published by Springer Berlin.
Checked against the index lists dated .
ISSN 2192-8304Verify ISSN ↗2192-8312Verify ISSN ↗
Publisher: Springer Berlin
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 70 / 144 | 51st | Q2 |
| Internal Medicine | 88 / 179 | 51st | Q2 |
| Endocrinology, Diabetes and Metabolism | 157 / 250 | 37th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q2, CiteScore 3.3.
JIMD Reports is Q2 in Biochemistry, Genetics and Molecular Biology (miscellaneous) (rank 70 of 144), Q2 in Internal Medicine (rank 88 of 179) and Q3 in Endocrinology, Diabetes and Metabolism (rank 157 of 250), by CiteScore 2025.
JIMD Reports is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.3, which places it in quartile Q2 at the 51st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.530, quartile Q2, with an H-index of 40.
The publisher lists an article processing charge of about US$2,200 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
JIMD Reports is published by Springer Berlin. Its print ISSN is 2192-8304 and its online ISSN is 2192-8312.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
JIMD Reports has an h-index of 46 and a 2-year mean of 0.8 citations per paper (OpenAlex). Its Scopus CiteScore is 3.3, quartile Q2. On 2-year citations it ranks #106 of 141 Scopus journals in Biochemistry, Genetics and Molecular Biology (miscellaneous).
JIMD Reports published 78 papers in 2025; its busiest recent year was 2020 with 106. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from United States (22.9%), United Kingdom (14%) and Australia (9.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.